Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature;Primäre radiochemotherapie inoperabler fortgeschrittener ösophaguskarzinome. Ergebnisse einer phase-II-studie und literaturübersicht

Strahlentherapie und Onkologie

Volumn 179, Issue 5, 2003, Pages 328-336

  Fritz, Peter ^a,b   Stoll, Peter ^c   Wannenmacher, Michael ^a   Zierhut, Dietmar ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b St Marien Krankenhaus Siegen gem GmbH   (Germany)

^c Klinikum Schwabing   (Germany)

Author keywords

Concurrent radiochemotherapy; Esophageal carcinoma; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

AGE; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; ESOPHAGUS CARCINOMA; FOOD INTAKE; HUMAN; PHASE 2 CLINICAL TRIAL; PROGNOSIS; RADIATION DOSE; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGE FACTORS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; KARNOFSKY PERFORMANCE STATUS; LYMPHATIC METASTASIS; MALE; META-ANALYSIS; MIDDLE AGED; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0038813948     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1038-8     Document Type: Article

References (55)

1. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B. Progress report of combined chemoradio-therapy versus radiotherapy alone in patients with esophageal cancer: an Intergroup study. J Clin Oncol 1997;15:277-84.
2. Andersen AP, Berdal P, Edsmyr F, Hagen S, Hatlevoll R, Nygaard K, Ottosen P, Peterffy P, Kongsholm H, Elgen K. Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. Radiother Oncology 1984;2:179-88.
3. Araujo CMM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, Pinto LHJ, Canary PCV. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus, Cancer 1991;67:2258-61.
4. Becker N, Wahrendorf J. Krebsatlas der Bundesrepublik Deutschland 1981-1990, 3. Aufl. Bertin-Heidelberg: Springer, 1997.
5. Benulic T, Jancar B. Treatment of advanced esophageal cancer by means of irradiation, cisplatinum and 5-fluorouracil. Neoplasma 1995;42:141-5.
6. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB. Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trial and historical control studies. Ann Oncol 1996;7:355-9.
7. Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Urmacher C, Brennan MF. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Abdom Gastrointest Radiol 1991;181:419-25.
8. Caspers RJL, Welvaart K, Verkes RJ, Hermans J, Leer JWH. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol. 1988;12:15-23,
9. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
10. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL. Chemoradiotherapy of locylly advanced esophageal cancer. Longterm follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999;281:1623-7.
11. Dunst J, Sauer R. Simultane Radiochemotherapie. [Übersicht]. Strahlenther Onkol 1993;169:205-12.
12. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. I. A critical review of radiotherapy. Br J Surg 1980;67:457-61.
13. Earle JD, Gelber RD, Moertel CG, Hahn RG. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1980;6:821-6.
14. Fietkau R, Kundt G. Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma. Strahlenther Onkol 2001;177:372-3. Kommentar.
15. Fritz P, Schraube P, Oberle J, Wannenmacher M, Friedl P. Perkutan-endokavitäire Strahlenbehandlung der Ösophaguskarzinome. Strahlenther Onkol 1992;168:154-61.
16. Fritz P, Wannenmacher M. Die Strahlenbehandlung in der multimodalen Therapie des Ösophaguskarzinom. Strahlenther Onkol 1997;173:295-308.
17. Giovannini M, Seitz JF, Thomas P, Hannoun-Levy JM, Perrier H, Resbeut M, Delpero JR, Fuentes P. Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer. Endoscopy 1997;29:4-9.
18. Greiner R, Skaleric K, Ehrengruber H. Prognostische Kriteren und Voraussetzungen einer kurativen Therapie des Oesophaguscarcinoms bei alleiniger Strahlentherapie. Radiologe 1979;19:254-61.
19. Hatlevoll R, Hagen S, Hansen HS, Hultvorn R, Jakobsen A, Mäntylä M, Modig H, Munck-Wikland E, Nygaard K, Rosengren B, Tausjf J, Elgen K. Bleomycin/cisplatin as neoadjuvant chermotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study: the second Scancinavian trial in esophageal cancer. Radiother Oncol 1992;24:114-6.
20. Hejna M, Kornek GV, Schratter-Sehn AU, Zach M, Schoder M, Raderer M, Rosen H, Schiessel R, Scheithauer W. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Cancer 1996;78:1646-50,
21. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326,1593-8.
22. Hishikawa Y, Miura T, Oshitani T, Yoshimura H, Ono K, Takahashi M, Nakajima T, Murakami M, Ikeda H, Imanaka K, Chatani M, Inoue T. A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma. Dis esophagus 1991;4:85-90.
23. Iizuka T, Isono K, Kakegawa T, Watanabe H. Parameters linked to ten-year survivial in Japan of resected esophageal carcinoma. Chest 1989;5: 1005-11.
24. Isenberg G, Chak A, Canto MI, Levitan N, Clayman J, Pollack BJ, Svak V Jr. Endoscopic ultrasoung in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc 1998;48:158-63.
25. Izquierdo MA, Marcuello E, de Segura GG, et at. Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy. Cancer 1993;71:287-92.
26. Kaneta R, Takai Y, Nomoto K, Kakuto Y, Ogawa Y, Arga H, et al. Effect of combination chemotherapy with daily low-dose CDDP for esophageal cancer: results of a randomized trial. Jpn J Cancer Chemother 1997;24: 2099-104.
27. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-56.
28. Kavanagh B, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen D, Staub W, Montana G, Crawford J, Wolfe W. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 1992;24:633-42.
29. Kovacs G. Percutaneous radiotherapy plus brachytherapy and concurrent chemotherapy for patients with localized esophageal carcinoma - Radiation Oncology Group Study 9207. Strahlenther Onkol 2001;177:269-70. Kommentar.
30. Laterza E, de Manzoni G, Gugtielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999;67: 1466-9.
31. Lissner J, Willich N. Die derzeitige Stellung der Strahlentherapie in der Behandtung des Ösophaguskarzinoms. Langenbecks Arch Chir Suppl Kongressbd 1990;II:111-6.
32. Lightdale CJ. Staging of esophageal cancer I: endoscopic ultrasonography. Semin Oncol 1994;21:438-6.
33. Lu XJ, Miao RH, Li XQ. Combination of selective arterial infusion chemotherapy with radiotherapy in the treatment of advanced esophageal carcinoma. Chin J Clin Oncol 1995;22:262-5.
34. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg RJ, Pajak T, Salter M, Benson AB. Final report of Intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999;43:517-23.
35. Mücke R, Ziegler PG, Libera T, Klautke G, Fietkau R. Multimodale Therapie des fortgeschrittenen inoperabten Ösophaguskarzinom. Eine retrospektive Analyse. Strahlenther Onkol 2000;176:350-5.
36. Müller JM, Erasmi H, Steltner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845.
37. Müller JM, Jacobi C, Zieren U, Adili F, Kaspers A. Die chirurgsche Behandlung des Speiseröhrenkarzinoms: Teil I. Europäische Ergebnisse 1980-1991. Zentralbl Chir 1992;117:311-24.
38. Ohtsu A, Yoshida S, Boku N, et al. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus. Jpn J Clin Oncol 1995;25:261-6.
39. Pichlmaier J, Müller JM, Zieren U. Plattenepithelcarcinom des Ösophagus. Chirurg 1992;63:701-8.
40. Röder HU, Valchera A, Heinsohn C, Schmidt B. Strahlentherapie des Ösophaguskarzinoms: Auswertung des Tübinger Patientenkollektivs 1977 bis 1982. Strahlenther Onkol 1989;165:1-10.
41. Roussel A, Bleiberg H, Dalesio O, Jacob JH, Haegele P, Jung GM, Paillot B, Heintz JF, Gignoux M, Nasca S, Namer A, Buyse M, Duez N. Palliative therapy of inoperable oesophagial carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys 1989;16:67-72.
42. Roussel A, Haegele P, Paillot B, Gignoux M, Marinus A, Sahmoud T, Bleiberg H. Results of the EORTC-GTCCG Phase III trial of irradiation versus irradiation and CDDP in inoperable esophageal cancer. For the Gastrointestinal Tract Cancer Cooperative Group. Proc Am Soc Clin Oncol 1994;13:583.abstract
43. Seitz JF, Giovannini M, Padaut-Cesana J, Fuentes P, Giudicelli R, Gauthier AP, Carcassonne Y. Inoperable nonmetastatic squamous cell carcinoma of the esophagus mamaged by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 1990;66:214-9.
44. Slabber CR, Nel JS, Schoeman L, Burger W, Falkson G, Falkson CI. A randomized study of radiotherapy alone versus radtiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998;21:462-5.
45. Stuschke M, Stahl M, Wilke H, Walz M, Oldenburg A, Stüben G, Seeber S, Sack H. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advenced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. Am J Clin Oncol 2000; 23:233-8.
46. Takemoto T, Ito T, Aibe T, Okita K. Endoscopic ultrasonography in the diagnosis of esophageal carcinoma with particular regard to staging it for operability. Endoscopy 1986;18:22-25.
47. Tio TL, Cohen P, Coene PP, Udding J, Den Hartog Jager FCA, Tytgat GNJ. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology 1989;96:1478-86.
48. Urba SG, Turdsi III AT. Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 1995;75:435-9.
49. Valerdi JJ, Tejedor M, Illarramendi JJ, et al. Neoadjuvant chemotherapy and radiotherapy in locally advanced esophagus carcinoma: long-term results. Int J Radiat Oncol Biol Phys 1993;27:843-7.
50. Voss AC, Seeliger HC. Das inoperable Ösophaguskarzinom. Ergebnisse der Strahlentherapie und Folgerungen für die Bestrahlungsplanung. Strahlentherapie 1979;155:230-6.
51. Wara WM, Mauch PM, Thomas AN, Phillips TL. Palliation for carcinoma of the esophagus. Radiology 1976;121:717-20.
52. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). Oxford: The Cochrane Library, Issue 4, Update Software.
53. Zenone T, Romestaing P, Lambert R, Gerard JP. Curative non-surgical combined treatment of squamous cell carcinoma of the oesophagus. Eur J Cancer 1992;28A:1380-6.
54. Zhang A. Radiation combined with bleomycin for esophageal carcinoma a randomized study of 99 patients. Chung Hua Chung Liu Tsa Chih 1984; 6:372-4.
55. Zhou JC. Randomized trial of combined chermotherapy including high dose cisplatin and radiotherapy for esophageal cancer [Chinese]. Chung Hua Chung Liu Tsa Chih 1991;13:291-4.